India trials of Russian Sputnik-V vaccine may end as early as March: Dr Reddy's
The company expects to enrol 100 participants for the mid-stage trial and 1,500 people for the late-stage.
Full Article
India trials of Russian Sputnik-V vaccine may end as early as March: Dr Reddy's
DNA
0 shares
1 views
You might like
Related news coverage
Long Road Ahead To COVID-19 Immunity Even With Vaccines – OpEd
Eurasia Review
By Prabir Purkayastha*
As the pandemic continues to spread throughout the world, many countries seem to have given up..
-
Russia's 'Sputnik V' COVID-19 vaccine gets nod for clinical trials in India
DNA
-
Dr Reddy's gets DCGI go-ahead to conduct Phase 2/3 human trials of Sputnik V in India
IndiaTimes
-
Sputnik V Covid-19 vaccine gets nod for clinical trials in India
Mid-Day
-
Dr Reddy's gets DCGI nod for trial of Covid vaccine Sputnik V in India
IndiaTimes